The use of adenosine in the treatment of a high-flow vein of Galen malformation in an adult.
Publication/Presentation Date
7-1-2014
Abstract
The treatment of high-flow vein of Galen aneurysmal malformations (VGAM) remains a therapeutic challenge for the neurosurgeon and the neurointerventionalist, as it is associated with high morbidity and mortality rates despite recent advances in open cranial surgery and interventional neuroradiology. A 37-year-old patient presented with a history of non-specific headaches. He had a history of heart failure since birth that was caused by an untreated VGAM. Intravenous boluses of adenosine were injected as an attempt to slow down the arteriovenous shunting of a VGAM prior to endovascular treatment. Adenosine can be a very useful adjunct in patients with extremely high arteriovenous shunting. n-butyl cyanoacrylate (n-BCA) should be the embolic material of choice due to its quick polymerization and adhesive properties.
Volume
21
Issue
7
First Page
1259
Last Page
1261
ISSN
1532-2653
Published In/Presented At
Tsimpas, A., Chalouhi, N., Halevy, J. D., Tjoumakaris, S., Gonzalez, L. F., Monteith, S. J., Dumont, A. S., Rosenwasser, R., & Jabbour, P. (2014). The use of adenosine in the treatment of a high-flow vein of Galen malformation in an adult. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 21(7), 1259–1261. https://doi.org/10.1016/j.jocn.2013.11.014
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
24491583
Department(s)
Administration and Leadership
Document Type
Article